logo
International Conference and Exhibition on
Pharmacovigilance and Clinical Trials
October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA
 
Pharmacovigilance-2012

    Previous Events
     
     
    Participants List from Academia
    Untitled Document
    Harvard University, USA

    University of Illinois, USA

    Vanderbilt University, USA

    University of Aberdeen, UK

    University of Greenwich, UK

    The Ohio State University, USA

    University of Cincinnati, USA

    University of Texas, USA

    University of Minnesota, USA

    Boston University School of Medicine, USA

    University of North Carolina, USA

    University of Pittsburgh, USA

    Chiba University, Japan

    University of Copenhagen, Denmark

    Panteion University, Greece

    Taif University, Saudi Arabia

    University Medical Center, Netherlands

    Monash University, Australia
     
    Participants List from Business
    Untitled Document
    Ambit Biosciences Corporation, USA

    HAL Allergy, Netherlands

    OptumInsight, USA

    InvaGen Pharmaceuticals, USA

    University Hospital Zurich, Switzerland

    St. Antoine Hospital, France

    Vigilex B.V, Netherlands

    Reckitt Benckiser, Russia

    3S-Pharmacological Consultation & Research GmbH, Germany

    Abbott Laboratories, USA

    Central Drug Research Institute, India

    Cadila Pharmaceuticals, India

    Alcon Laboratories Inc., USA

    Janssen Pharmaceutical Companies of Johnson & Johnson, USA
     
    Upcoming Conferences
    Day 1
    Scientific Program
      Day 2
    Scientific Program
      Day 3
    Scientific Program
    International Conference and Exhibition on Pharmacovigilance and Clinical Trials, will be organized around the theme "Safer Drugs and Good Clinical Practice."

    Pharmacovigilance-2012 is comprised of 10 tracks and 43 sessions designed to offer comprehensive sessions that address current issues in Pharmacovigilance and Clinical Trials.

    Submit your abstract to any of the following tracks. All related abstracts are accepted.

    Register now for the conference by choosing an appropriate package suitable to you.
    Abstract Submission   Register
    Track 1: Pharmacovigilance and its Challenges
    Track 1-1 Role of pharmacovigilance in health regulation
    Track 1-2 International collaboration and new pharmacovigilance legislation
    Track 1-3 Role of pharma industries in the improvement of pharmacovigilance system
    Track 1-4 Fatality of pharmacovigilance failure
    Track 1-5 Detection & evaluation of drug safety signals
    Track 2: Role of Clinical Trials
    Track 2-1 Data collection and quality control
    Track 2-2 Alternative trials design and models
    Track 2-3 Multi center trials and monitoring
    Track 2-4 Practice of good and ethical clinical trials
    Track 3: Clinical Trials on Diseases
    Track 3-1 Recent clinical trials on Alzheimer's disease
    Track 3-2 Recent clinical trials on Parkinson’s disease
    Track 3-3 Clinical trials on cancer
    Track 3-4 Applications of biomarkers in clinical trials
    Track 3-5 Emerging technology in clinical trials
    Track 4: Adverse Drug Reactions
    Track 4-1 Assessing & reporting adverse drug reactions
    Track 4-2 Reduction of adverse drug reaction by nano technology
    Track 4-3 Expected and un-expected drug reactions and its reporting
    Track 4-4 Drugs in human pregnancy and nursing
    Track 4-5 Pharmacotherapy and Pharmacogenomics
    Track 4-6 Post marketing reports on adverse effects
    Track 5: Drug Interactions
    Track 5-1 Advances of pharmacokinetic interactions
    Track 5-2 Advances of pharmacodynamic interactions
    Track 5-3 Drug and substance abuse
    Track 5-4 Drug-drug interactions
    Track 5-5 Pharmacoenvironmentology
    Track 6: Pharmacy Practices and Its Challenges
    Track 6-1 Pharmacy practice and its guidelines
    Track 6-2 Challenges in compounding and dispensing practice
    Track 6-3 Drug toxicity and drug safety measures
    Track 6-4 Pharmacoepidemiology of drug shortages
    Track 7: Regulatory Affairs
    Track 7-1 Role of regulatory affairs in pharmacovigilance
    Track 7-2 Role of regulatory agencies in safe medicines and medical devices
    Track 7-3 Risk minimization tools
    Track 8: Risk Management: New Approaching Paradigm for Pharmacovigilance
    Track 8-1 Information technology in Pharmacovigilance and promoting companies
    Track 8-2 Review of software’s used in pharmacovigilance and clinical trials
    Track 8-3 Risk communication: Interface between pharmacovigilance, sales and marketing
    Track 8-4 Risk management versus recent market withdrawal
    Track 8-5 Monitoring unlicensed, off labels and orphan drugs
    Track 9: Clinical Research and Statistics
    Track 9-1 Guidelines for clinical research and its statistics
    Track 9-2 Advanced Information technology in clinical trials and promoting companies
    Track 9-3 Data mining concepts and techniques
    Track 10: Strategies for Growth in Pharma Environment
    Track 10-1 Strategic development towards FDA Approval
    Track 10-2 Advances in changing pharmacovigilance regulation system
    Track 10-3 Post market product surveillances
     
    follow
    Conference Secretariat: Pharmacovigilance-2012, OMICS Group Conferences
    5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
    Phone: +1-650-268-9744 l Fax: +1-650-618-1414
    Toll free: 1-800-216-6499(USA & Canada) l 1-800-651-097(Australia) l 0805-080048(Europe)
    Email: pharmacovigilance2012@omicsonline.com
    Operated by: Editors -: Journal of Clinical Trials, Journal of Clinical & Experimental Pharmacology and Journal of Clinical Pharmacology & Biopharmaceutics
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version